Fig.3.A,A1,C,E,C1,J

Kowalczyk I et al. (2021)

Xla Wt + lrp2 MO

NF16 (immunohistochemistry)

Anatomical Phenotype
abnormal apical constriction abnormal development of optic vesicle

Expression Phenotype
decreased amount actb.L expression in neural plate

Fig. 4. F

Yasunaga T et al. (2015)

Xla Wt + daam1 MO

NF32-33/34 (immunohistochemistry)

Expression Phenotype
mislocalised actb.L expression in actin cytoskeleton

Fig. 5.D

Yasunaga T et al. (2015)

Xla Wt + intu MO

NF32-33/34 (immunohistochemistry)

Expression Phenotype
mislocalised actb.L expression in actin cytoskeleton

Fig. 5.G

Yasunaga T et al. (2015)

Xla Wt + intu MO

NF32-33/34 (immunohistochemistry)

Expression Phenotype
decreased amount actb.L expression in actin cytoskeleton

Fig. 2. E

Yasunaga T et al. (2015)

Xla Wt + nphp4 MO

NF32-33/34 (immunohistochemistry)

Expression Phenotype
decreased amount actb.L expression in actin cytoskeleton

Fig. 3. A

Yasunaga T et al. (2015)

Xla Wt + nphp4 MO

NF32-33/34 (immunohistochemistry)

Expression Phenotype
mislocalised actb.L expression in actin cytoskeleton

Fig. 5.G

Yasunaga T et al. (2015)

Xla Wt + nphp4 MO

NF32-33/34 (immunohistochemistry)

Expression Phenotype
decreased amount actb.L expression in actin cytoskeleton

fig S5.b

Li Y et al. (2008)

Xla Wt + sfrp5 MO

NF20 (immunohistochemistry)

Anatomical Phenotype
abnormally localised actin filament abnormally localised foregut

Expression Phenotype
mislocalised actb.L expression in foregut epithelium